Lv7
4150 积分 2023-09-04 加入
Squamous Non-Small Cell Lung Cancer: Current and Emerging Treatment Options
23天前
已完结
Sugemalimab versus placebo, in combination with platinum-based chemotherapy, as first-line treatment of metastatic non-small-cell lung cancer (GEMSTONE-302): interim and final analyses of a double-blind, randomised, phase 3 clinical trial
1个月前
已完结
Toripalimab Plus Chemotherapy for Patients With Treatment-Naive Advanced Non–Small-Cell Lung Cancer: A Multicenter Randomized Phase III Trial (CHOICE-01)
1个月前
已完结
A global phase 3 study of serplulimab plus chemotherapy as first-line treatment for advanced squamous non-small-cell lung cancer (ASTRUM-004)
1个月前
已完结
First-line penpulimab combined with paclitaxel and carboplatin for metastatic squamous non-small-cell lung cancer in China (AK105-302): a multicentre, randomised, double-blind, placebo-controlled phase 3 clinical trial
1个月前
已完结
Strategies for overcoming tumour resistance to immunotherapy: harnessing the power of radiation therapy
1个月前
已完结
Reframing the paradigm: stereotactic body radiation therapy as an engineer of the tumor immune microenvironment
1个月前
已完结
Combination treatment of HCC with SBRT and immune checkpoint inhibition
1个月前
已完结
Immunologic tumor microenvironment modulators for turning cold tumors hot
1个月前
已完结
Pembrolizumab Plus Chemotherapy in Squamous Non–Small-Cell Lung Cancer: 5-Year Update of the Phase III KEYNOTE-407 Study
1个月前
已完结
皖公网安备34019202002308
